Moneygram has deployed an active Solana validator node and joined the Solana Developer Platform. Rather than an immediate integration with its retail remittance engine, this serves as an infrastructure staging ground to master public-node challenges before exposing its core settlement ledger.
Key Takeaways
Moneygram recently became a Solana validator to master node operations before ledger integration.Apprehension grows over compliant order lanes as Solana risks centralizing liquidity into 1 approved route.Flowra’s PBP framework will next let institutional nodes block 100% of toxic MEV via programmable policies.Yet as traditional financial institutions (TradFi) step into permissionless consensus layers, they face significant engineering, security and economic friction. Harry Hwang, CEO of Flowra, breaks down the architectural realities, zero-trust requirements, regulatory tightropes and the emerging fight over compliant institutional MEV.
Meanwhile, when a heavily regulated entity participates in consensus, it effectively confirms transactions for a global pool of pseudonymous users—creating tension with compliance mandates.
“When a payment company directly participates in consensus on a public permissionless network, it is not yet fully settled how that activity should be treated under AML, sanctions, the Travel Rule, payment licensing, outsourcing and operational resilience frameworks,” Hwang said.
Compliant Order-Flow and Base-Layer Neutrality Risks“In practice, this demand is more likely to evolve into compliant order-flow lanes, policy-based execution and permissioned asset layers. For example, institutional orders may be routed through KYT-screened paths, while validators select execution routes based on policies such as no-sandwich, low-risk, no-toxic MEV or compliance-friendly flow.”
To maintain validator autonomy, Flowra uses a policy-based proposer (PBP) framework. The goal, Hwang said, is not to lock validators into a single builder or block engine, but to allow them to choose among multiple builders and order-flow sources based on yield, toxicity, risk, and compliance criteria.
“This question is not really about whether institutions should participate in MEV or not. It is about which forms of MEV should be allowed and which should be restricted,” Hwang said. “If an institutional operator gives up MEV entirely, it may be leaving revenue on the table that could otherwise go to delegators or investors.”
But if it allows aggressive MEV strategies without limits, especially strategies built on user harm, it may conflict with fiduciary duty and market conduct standards.
